Efficacy of Marine By-product Hydrolysate on the Reduction of Atopic Dermatitis Symptoms

Inclusion Criteria: * Phototype: I to V; * Subjects with atopic skin (with at least 1 visible xerosis + inflammation on the body); * Subjects with a history background of asthma, rhinitis and/or allergic conjunctivitis; * Subjects with SCORAD between 8 and 30 (at least 50% or more having around 8-10); * Subjects with BMI between 20 and 30 kg/m2 (limits included); * Subjects who have not recently participated in another similar study; * Willingness to take supplements for the duration of the study; * Willingness not to use products likely to interfere with the test product (collagen, hyaluronic acid, anti-stress products); * Willingness not to change lifestyle habits; * Willingness to avoid intensive UV exposure; * Use of contraception that should not be modified during the study. * Healthy subject; * Mentally healthy subject according to Investigator's opinion; * Subject having given his/her free informed, written consent; * Subject agrees to taking photograph and then use the image after its pseudonymization; * Subject willing to adhere to the protocol and study procedures; * Subject able to understand the study; * Subject available to attend the study visits. Exclusion Criteria: * Pregnant or nursing woman or woman planning to get pregnant during the study; * Cutaneous marks on the experimental areas, which could interfere with the assessment of skin reactions; * Subjects who have participated in the last 3 months or are currently participating in another clinical trial that may interfere with the evaluation of the primary endpoint (endpoint AD); * Current administration of antibiotics; * Known history of chronic disease such as congenital heart disease, liver or kidney disease, or immune deficiency; * Topical treatment with immunomodulators (tacrolimus or pimecrolimus) in the three months prior to registration; * Application of moisturizing products on the experimental area the day of the inclusion of the study; * Acute or chronic infectious diseases; * Not meet inclusion criteria; * Those undergoing aesthetic medicine (fillers, hyaluronic acid injections, botox) that could interference in the experimental area; * Subjects suffering Alimentary/Eating disorders (i.e. bulimia, psychogenic eating disorders, etc.) * Subjects having frequent stomach burn; * Allergy or intolerance to any ingredient of the experimental food supplement; * Subjects with diabetes mellitus; * Fish and/or iodine allergy; * Intestinal conditions or disorders (Crohn's disease, colitis, irritable bowel syndrome, intestinal malabsorption...) * Recent change, forecast of initiation of an hormonal treatment or change of the usual hormonal treatment during the study or 3 months before the starting of the study; * Subject having undergone a surgery under general anesthesia within the previous month; * Exposure in UVA ray sunbed during the 3 months before the start of the study on the experimental area or during the study; * Subjects protected by the law; * Subject employed by EUROFINS PRODUCT TESTING, COSMETICS \& PERSONAL CARE SPAIN, S.L.U.